PRMT4-Mediated Arginine Methylation Negatively Regulates Retinoblastoma Tumor Suppressor Protein and Promotes E2F-1 Dissociation

REFERENCES

• Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330. http://dx.doi.org/10.1016/0092-8674(95)90385-2.
   PubMed Web of Science ®Google Scholar
• Massagué J. 2004. G1 cell-cycle control and cancer. Nature 432:298–306. http://dx.doi.org/10.1038/nature03094.
   PubMed Web of Science ®Google Scholar
• Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13:7813–7825.
   PubMed Web of Science ®Google Scholar
• Shan B, Zhu X, Chen PL, Durfee T, Yang Y, Sharp D, Lee WH. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol 12:5620–5631.
   PubMed Web of Science ®Google Scholar
• Graña X, Garriga J, Mayol X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365–3383.
   PubMed Web of Science ®Google Scholar
• DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095. http://dx.doi.org/10.1016/0092-8674(89)90507-2.
   PubMed Web of Science ®Google Scholar
• Helin K, Harlow E, Fattaey A. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501–6508.
   PubMed Web of Science ®Google Scholar
• Hiebert SW. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 13:3384–3391.
   PubMed Web of Science ®Google Scholar
• Rubin SM, Gall AL, Zheng N, Pavletich NP. 2005. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123:1093–1106. http://dx.doi.org/10.1016/j.cell.2005.09.044.
   PubMed Web of Science ®Google Scholar
• Lee C, Chang JH, Lee HS, Cho Y. 2002. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev 16:3199–3212. http://dx.doi.org/10.1101/gad.1046102.
   PubMed Web of Science ®Google Scholar
• Buchkovich K, Duffy LA, Harlow E. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105. http://dx.doi.org/10.1016/0092-8674(89)90508-4.
   PubMed Web of Science ®Google Scholar
• Lundberg AS, Weinberg RA. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753–761.
   PubMed Web of Science ®Google Scholar
• Brown VD, Phillips RA, Gallie BL. 1999. Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol 19:3246–3256.
   PubMed Web of Science ®Google Scholar
• Mittnacht S. 1998. Control of pRB phosphorylation. Curr Opin Genet Dev 8:21–27. http://dx.doi.org/10.1016/S0959-437X(98)80057-9.
   PubMed Web of Science ®Google Scholar
• Burke JR, Deshong AJ, Pelton JG, Rubin SM. 2010. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 285:16286–16293. http://dx.doi.org/10.1074/jbc.M110.108167.
   PubMed Web of Science ®Google Scholar
• Burke JR, Hura GL, Rubin SM. 2012. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev 26:1156–1166. http://dx.doi.org/10.1101/gad.189837.112.
   PubMedGoogle Scholar
• DeGregori J, Kowalik T, Nevins JR. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 15:4215–4224.
   PubMed Web of Science ®Google Scholar
• Qin XQ, Chittenden T, Livingston DM, Kaelin WG, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:953–964. http://dx.doi.org/10.1101/gad.6.6.953.
   PubMed Web of Science ®Google Scholar
• Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177–185. http://dx.doi.org/10.1101/gad.6.2.177.
   PubMed Web of Science ®Google Scholar
• Knudsen ES, Wang JY. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 271:8313–8320. http://dx.doi.org/10.1074/jbc.271.14.8313.
   PubMed Web of Science ®Google Scholar
• Burke JR, Liban TJ, Restrepo T, Lee HW, Rubin SM. 2014. Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain. J Mol Biol 426:245–255. http://dx.doi.org/10.1016/j.jmb.2013.09.031.
   PubMed Web of Science ®Google Scholar
• Nguyen DX, Baglia LA, Huang SM, Baker CM, McCance DJ. 2004. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein. EMBO J 23:1609–1618. http://dx.doi.org/10.1038/sj.emboj.7600176.
   PubMedGoogle Scholar
• Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB. 2001. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3:667–674. http://dx.doi.org/10.1038/35083062.
   PubMed Web of Science ®Google Scholar
• Markham D, Munro S, Soloway J, O'Connor DP, La Thangue NB. 2006. DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep 7:192–198. http://dx.doi.org/10.1038/sj.embor.7400591.
   PubMed Web of Science ®Google Scholar
• Ledl A, Schmidt D, Muller S. 2005. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 24:3810–3818. http://dx.doi.org/10.1038/sj.onc.1208539.
   PubMed Web of Science ®Google Scholar
• Kalejta RF, Shenk T. 2003. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci U S A 100:3263–3268. http://dx.doi.org/10.1073/pnas.0538058100.
   PubMed Web of Science ®Google Scholar
• Ying H, Xiao ZX. 2006. Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 5:506–508. http://dx.doi.org/10.4161/cc.5.5.2515.
   PubMed Web of Science ®Google Scholar
• Carr SM, Munro S, Kessler B, Oppermann U, La Thangue NB. 2011. Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J 30:317–327. http://dx.doi.org/10.1038/emboj.2010.311.
   PubMed Web of Science ®Google Scholar
• Munro S, Khaire N, Inche A, Carr S, La Thangue NB. 2010. Lysine methylation regulates the pRb tumour suppressor protein. Oncogene 29:2357–2367. http://dx.doi.org/10.1038/onc.2009.511.
   PubMed Web of Science ®Google Scholar
• Macdonald JI, Dick FA. 2012. Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer 3:619–633. http://dx.doi.org/10.1177/1947601912473305.
   PubMedGoogle Scholar
• Saddic LA, West LE, Aslanian A, Yates JR, III, Rubin SM, Gozani O, Sage J. 2010. Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem 285:37733–37740. http://dx.doi.org/10.1074/jbc.M110.137612.
   PubMed Web of Science ®Google Scholar
• Wang X, Roberts CW. 2014. CARMA: CARM1 methylation of SWI/SNF in breast cancer. Cancer Cell 25:3–4. http://dx.doi.org/10.1016/j.ccr.2013.12.017.
   PubMedGoogle Scholar
• Bedford MT, Clarke SG. 2009. Protein arginine methylation in mammals: who, what, and why. Mol Cell 33:1–13. http://dx.doi.org/10.1016/j.molcel.2008.12.013.
   PubMed Web of Science ®Google Scholar
• Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR. 1999. Regulation of transcription by a protein methyltransferase. Science 284:2174–2177. http://dx.doi.org/10.1126/science.284.5423.2174.
   PubMed Web of Science ®Google Scholar
• Bauer UM, Daujat S, Nielsen SJ, Nightingale K, Kouzarides T. 2002. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep 3:39–44. http://dx.doi.org/10.1093/embo-reports/kvf013.
   PubMed Web of Science ®Google Scholar
• Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, Lombardi C, Imhof R, Bedford MT, Natoli G, Hottiger MO. 2005. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-κB-dependent gene expression. EMBO J 24:85–96. http://dx.doi.org/10.1038/sj.emboj.7600500.
   PubMed Web of Science ®Google Scholar
• Fauquier L, Duboe C, Jore C, Trouche D, Vandel L. 2008. Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes. FASEB J 22:3337–3347. http://dx.doi.org/10.1096/fj.07-104604.
   PubMedGoogle Scholar
• An W, Kim J, Roeder RG. 2004. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117:735–748. http://dx.doi.org/10.1016/j.cell.2004.05.009.
   PubMed Web of Science ®Google Scholar
• El Messaoudi S, Fabbrizio E, Rodriguez C, Chuchana P, Fauquier L, Cheng D, Theillet C, Vandel L, Bedford MT, Sardet C. 2006. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the cyclin E1 gene. Proc Natl Acad Sci U S A 103:13351–13356. http://dx.doi.org/10.1073/pnas.0605692103.
   PubMed Web of Science ®Google Scholar
• Frietze S, Lupien M, Silver PA, Brown M. 2008. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res 68:301–306. http://dx.doi.org/10.1158/0008-5472.CAN-07-1983.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, Wisinski KB, Huang W, Cai W, Pike JW, Yuan M, Ahlquist P, Xu W. 2014. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell 25:21–36. http://dx.doi.org/10.1016/j.ccr.2013.12.007.
   PubMed Web of Science ®Google Scholar
• Dillon MB, Rust HL, Thompson PR, Mowen KA. 2013. Automethylation of protein arginine methyltransferase 8 (PRMT8) regulates activity by impeding S-adenosylmethionine sensitivity. J Biol Chem 288:27872–27880. http://dx.doi.org/10.1074/jbc.M113.491092.
   PubMed Web of Science ®Google Scholar
• Izumiya Y, Ellison TJ, Yeh ET, Jung JU, Luciw PA, Kung HJ. 2005. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J Virol 79:9912–9925. http://dx.doi.org/10.1128/JVI.79.15.9912-9925.2005.
   PubMedGoogle Scholar
• Izumiya Y, Izumiya C, Hsia D, Ellison TJ, Luciw PA, Kung HJ. 2009. NF-κB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jκ coactivator. J Virol 83:4435–4446. http://dx.doi.org/10.1128/JVI.01999-08.
   PubMedGoogle Scholar
• Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383–5392. http://dx.doi.org/10.1021/ac025747h.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646–4658. http://dx.doi.org/10.1021/ac0341261.
   PubMed Web of Science ®Google Scholar
• Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. 2004. Regulation of p53 activity through lysine methylation. Nature 432:353–360. http://dx.doi.org/10.1038/nature03117.
   PubMed Web of Science ®Google Scholar
• Campbell M, Chang PC, Huerta S, Izumiya C, Davis R, Tepper CG, Kim KY, Shevchenko B, Wang DH, Jung JU, Luciw PA, Kung HJ, Izumiya Y. 2012. Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen. J Biol Chem 287:5806–5818. http://dx.doi.org/10.1074/jbc.M111.289496.
   PubMedGoogle Scholar
• Lee YH, Koh SS, Zhang X, Cheng X, Stallcup MR. 2002. Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. Mol Cell Biol 22:3621–3632. http://dx.doi.org/10.1128/MCB.22.11.3621-3632.2002.
   PubMedGoogle Scholar
• Parfitt DE, Zernicka-Goetz M. 2010. Epigenetic modification affecting expression of cell polarity and cell fate genes to regulate lineage specification in the early mouse embryo. Mol Biol Cell 21:2649–2660. http://dx.doi.org/10.1091/mbc.E10-01-0053.
   PubMedGoogle Scholar
• Lee YH, Bedford MT, Stallcup MR. 2011. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation. Genes Dev 25:176–188. http://dx.doi.org/10.1101/gad.1975811.
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Boehm M, Olive M, Crook MF, San H, Langenickel T, Nabel EG. 2006. The arginine methyltransferase PRMT2 binds RB and regulates E2F function. Exp Cell Res 312:2040–2053. http://dx.doi.org/10.1016/j.yexcr.2006.03.001.
   PubMed Web of Science ®Google Scholar
• Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A. 2008. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol Cell 32:221–231. http://dx.doi.org/10.1016/j.molcel.2008.09.013.
   PubMed Web of Science ®Google Scholar
• Kowenz-Leutz E, Pless O, Dittmar G, Knoblich M, Leutz A. 2010. Crosstalk between C/EBPβ phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J 29:1105–1115. http://dx.doi.org/10.1038/emboj.2010.3.
   PubMed Web of Science ®Google Scholar
• Arita K, Isogai S, Oda T, Unoki M, Sugita K, Sekiyama N, Kuwata K, Hamamoto R, Tochio H, Sato M, Ariyoshi M, Shirakawa M. 2012. Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1. Proc Natl Acad Sci U S A 109:12950–12955. http://dx.doi.org/10.1073/pnas.1203701109.
   PubMedGoogle Scholar
• Park YB, Park MJ, Kimura K, Shimizu K, Lee SH, Yokota J. 2002. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet 133:105–111. http://dx.doi.org/10.1016/S0165-4608(01)00575-1.
   PubMedGoogle Scholar
• Bedford MT, Richard S. 2005. Arginine methylation an emerging regulator of protein function. Mol Cell 18:263–272. http://dx.doi.org/10.1016/j.molcel.2005.04.003.
   PubMed Web of Science ®Google Scholar
• Levy D, Liu CL, Yang Z, Newman AM, Alizadeh AA, Utz PJ, Gozani O. 2011. A proteomic approach for the identification of novel lysine methyltransferase substrates. Epigenetics Chromatin 4:19. http://dx.doi.org/10.1186/1756-8935-4-19.
   PubMed Web of Science ®Google Scholar
• Reference deleted.
   Google Scholar
• Cho HS, Hayami S, Toyokawa G, Maejima K, Yamane Y, Suzuki T, Dohmae N, Kogure M, Kang D, Neal DE, Ponder BA, Yamaue H, Nakamura Y, Hamamoto R. 2012. RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. Neoplasia 14:476–486.
   PubMed Web of Science ®Google Scholar
• Zheng S, Moehlenbrink J, Lu YC, Zalmas LP, Sagum CA, Carr S, McGouran JF, Alexander L, Fedorov O, Munro S, Kessler B, Bedford MT, Yu Q, La Thangue NB. 2013. Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1. Mol Cell 52:37–51. http://dx.doi.org/10.1016/j.molcel.2013.08.039.
   PubMed Web of Science ®Google Scholar
• Yang Y, Bedford MT. 2013. Protein arginine methyltransferases and cancer. Nat Rev Cancer 13:37–50. http://dx.doi.org/10.1038/nrc3409.
   PubMed Web of Science ®Google Scholar
• Streubel G, Bouchard C, Berberich H, Zeller MS, Teichmann S, Adamkiewicz J, Muller R, Klempnauer KH, Bauer UM. 2013. PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines. PLoS Genet 9:e1003343. http://dx.doi.org/10.1371/journal.pgen.1003343.
   PubMedGoogle Scholar
• Feng Q, He B, Jung SY, Song Y, Qin J, Tsai SY, Tsai MJ, O'Malley BW. 2009. Biochemical control of CARM1 enzymatic activity by phosphorylation. J Biol Chem 284:36167–36174. http://dx.doi.org/10.1074/jbc.M109.065524.
   PubMedGoogle Scholar
• Higashimoto K, Kuhn P, Desai D, Cheng X, Xu W. 2007. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc Natl Acad Sci U S A 104:12318–12323. http://dx.doi.org/10.1073/pnas.0610792104.
   PubMed Web of Science ®Google Scholar